Trade PCSA anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Processa Pharmaceuticals, Inc. (PCSA) is trading at US$2.06, down 2.37% today as of Aug 28, 10:15 EDT. The company has a market capitalisation of US$5.81M. Over the past 52 weeks, PCSA has traded between US$1.67 and US$14.24. On Syfe you can trade PCSA with $0 commission and add it to your watchlist.
| Previous close | US$2.11 |
|---|---|
| Market cap | US$5.81M |
| 52-week range | US$1.67 – US$14.24 |
| Volume | 15.78K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica. The company was founded by David Young, Patrick Lin, Sian E. Bigora, Wendy Guy, and Chang Rung Chen on March 29, 2011 and is headquartered in Vero Beach, FL.
Year: 2013
Processa Pharmaceuticals, Inc. (PCSA) stock is trading at US$2.06, -2.37% from the previous close of US$2.11.
The market cap for Processa Pharmaceuticals, Inc. (PCSA) stock is approximately US$5.81M.
The 52-week high for Processa Pharmaceuticals, Inc. (PCSA) stock is US$14.24.
The 52-week low for Processa Pharmaceuticals, Inc. (PCSA) stock is US$1.67.
Processa Pharmaceuticals, Inc. (PCSA) does not currently pay a dividend.
Stay on top of PCSA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
